Phase 1 COVID-19 Data and Connectivity – National Core Study (Phase 1 D&C-NCS)

第 1 阶段 COVID-19 数据和连接 — 国家核心研究(第 1 阶段 D

基本信息

  • 批准号:
    MC_PC_20058
  • 负责人:
  • 金额:
    $ 1936.78万
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Intramural
  • 财政年份:
    2021
  • 资助国家:
    英国
  • 起止时间:
    2021 至 无数据
  • 项目状态:
    已结题

项目摘要

The Data and Connectivity study sits across the other National Core Studies and delivers a national health data research capability to support COVID-19 research questions, ensuring datasets are discoverable and accessible and linkages are established to answer the priority research questions from the other five National Core Studies. Making data available for wider research use will increase the scope of benefits beyond the specific studies above, leading to unexpected benefits and boosting UK research capacity more generally, increasing return on investment for the NCS programme. Data integration and harmonisation of methods and standards will enable rapid research and development of new interventions and technologies across the spectrum of COVID-19, and knowledge and technology transfer to other clinical and public health areas. Collation and linkage between datasets is critical to bringing the core studies together, ensuring that each of them can deliver against their policy priorities e.g. hospital data may not currently be linked with GP data and wider community data (e.g. socioeconomic data or data on housing and the built environment). Access, cleaning, linkage and use of these datasets together is needed to fully understand links between these factors and outcomes.Delivery of the COVID-19 Data and Connectivity Study will involve close interaction with data custodians, the public and patients, and providers of UK-wide national Trusted Research Environments (TREs) to ensure the required data is stored safely and securely, made readily available to approved researchers and is associated with compute, analytical and data services that make it easier to address priority research questions in a transparent and trustworthy way.Phase 1 will:• Continue to respond to emerging COVID-19 research priorities, mapping key datasets required by the National Core Studies, NIHR UPH Studies and SAGE sub-groups to allow research which can inform policy and operational decision making across the UK• Further develop the data infrastructure and services across the UK to allow faster access to high priority health, administrative, molecular, and behavioural data assets for researchers working on the most important COVID-related studies, ensuring priority research questions can be answered efficiently, in a transparent and trustworthy way. • Strengthen and extend the existing national Trusted Research Environments (TRE) and UK Health Data Research Innovation Gateway infrastructure through inclusive four nations approach ensuring the priority datasets for COVID-19 research are findable, accessible, inter-operable and reusable (FAIR) as a single shop window
数据和连通性研究横跨其他国家核心研究,提供国家健康数据研究能力,以支持COVID-19研究问题,确保数据集可共享和可访问,并建立联系,以回答其他五项国家核心研究的优先研究问题。使数据可用于更广泛的研究用途将增加上述具体研究之外的效益范围,从而带来意想不到的效益,并更普遍地提高英国的研究能力,增加NCS计划的投资回报。数据整合以及方法和标准的协调将有助于快速研究和开发新的干预措施和技术,并将知识和技术转移到其他临床和公共卫生领域。数据集之间的整理和联系对于将核心研究集中在一起至关重要,确保每个研究都可以根据其政策优先事项提供,例如医院数据目前可能没有与GP数据和更广泛的社区数据(例如社会经济数据或住房和建筑环境数据)联系起来。为了充分理解这些因素和结果之间的联系,需要访问、清理、链接和使用这些数据集。COVID-19数据和连通性研究的交付将涉及与数据保管人、公众和患者以及英国全国可信研究环境(TREs)提供商的密切互动,以确保安全可靠地存储所需数据,该平台可随时供经批准的研究人员使用,并与计算、分析和数据服务相关联,使其更容易以透明和值得信赖的方式解决优先研究问题。第一阶段将:·继续应对新出现的COVID-19研究优先事项,绘制国家核心研究所需的关键数据集,NIHR UPH研究和SAGE小组,以允许研究,可以为英国各地的政策和运营决策提供信息·进一步发展英国各地的数据基础设施和服务,以允许更快地获得高优先级的健康,行政,分子,为从事最重要的COVID相关研究的研究人员提供行为数据资产,确保以透明和可信的方式有效回答优先研究问题。·通过包容性四国方法加强和扩展现有的国家可信研究环境(TRE)和英国健康数据研究创新网关基础设施,确保COVID-19研究的优先数据集作为单一商店窗口可查找,可访问,可互操作和可重复使用(FAIR)

项目成果

期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Harmonising electronic health records for reproducible research: challenges, solutions and recommendations from a UK-wide COVID-19 research collaboration.
  • DOI:
    10.1186/s12911-022-02093-0
  • 发表时间:
    2023-01-16
  • 期刊:
  • 影响因子:
    3.5
  • 作者:
    Abbasizanjani, Hoda;Torabi, Fatemeh;Bedston, Stuart;Bolton, Thomas;Davies, Gareth;Denaxas, Spiros;Griffiths, Rowena;Herbert, Laura;Hollings, Sam;Keene, Spencer;Khunti, Kamlesh;Lowthian, Emily;Lyons, Jane;Mizani, Mehrdad A.;Nolan, John;Sudlow, Cathie;Walker, Venexia;Whiteley, William;Wood, Angela;Akbari, Ashley
  • 通讯作者:
    Akbari, Ashley
Towards mitigating health inequity via machine learning: a nationwide cohort study to develop and validate ethnicity-specific models for prediction of cardiovascular disease risk in COVID-19 patients
通过机器学习减轻健康不平等:一项全国性队列研究,旨在开发和验证用于预测 COVID-19 患者心血管疾病风险的特定种族模型
  • DOI:
    10.1101/2023.09.13.23295489
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Allery F
  • 通讯作者:
    Allery F
Harmonising electronic health records for reproducible research: challenges, solutions and recommendations from a UK-wide COVID-19 research collaboration
协调电子健康记录以进行可重复的研究:英国范围内的 COVID-19 研究合作面临的挑战、解决方案和建议
  • DOI:
    10.21203/rs.3.rs-2109276/v1
  • 发表时间:
    2022
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Abbasizanjani H
  • 通讯作者:
    Abbasizanjani H
Ethnic inequalities in positive SARS-CoV-2 tests, infection prognosis, COVID-19 hospitalisations and deaths: analysis of 2 years of a record linked national cohort study in Scotland.
  • DOI:
    10.1136/jech-2023-220501
  • 发表时间:
    2023-10
  • 期刊:
  • 影响因子:
    6.3
  • 作者:
    Amele, Sarah;Kibuchi, Eliud;McCabe, Ronan;Pearce, Anna;Henery, Paul;Hainey, Kirsten;Fagbamigbe, Adeniyi Francis;Kurdi, Amanj;McCowan, Colin;Simpson, Colin R.;Dibben, Chris;Buchanan, Duncan;Demou, Evangelia;Almaghrabi, Fatima;Anghelescu, Gina;Taylor, Harry;Tibble, Holly;Rudan, Igor;Nazroo, James;Becares, Laia;Daines, Luke;Irizar, Patricia;Jayacodi, Sandra;Pattaro, Serena;Sheikh, Aziz;Katikireddi, Srinivasa Vittal
  • 通讯作者:
    Katikireddi, Srinivasa Vittal
COVID-19 hospital admissions and deaths after BNT162b2 and ChAdOx1 nCoV-19 vaccinations in 2·57 million people in Scotland (EAVE II): a prospective cohort study.
  • DOI:
    10.1016/s2213-2600(21)00380-5
  • 发表时间:
    2021-12
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Agrawal U;Katikireddi SV;McCowan C;Mulholland RH;Azcoaga-Lorenzo A;Amele S;Fagbamigbe AF;Vasileiou E;Grange Z;Shi T;Kerr S;Moore E;Murray JLK;Shah SA;Ritchie L;O'Reilly D;Stock SJ;Beggs J;Chuter A;Torabi F;Akbari A;Bedston S;McMenamin J;Wood R;Tang RSM;de Lusignan S;Hobbs FDR;Woolhouse M;Simpson CR;Robertson C;Sheikh A
  • 通讯作者:
    Sheikh A
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Andrew Morris其他文献

Creating sustainable innovation through design for behaviour change: full project report
通过行为改变设计创造可持续创新:完整的项目报告
  • DOI:
  • 发表时间:
    2014
  • 期刊:
  • 影响因子:
    0
  • 作者:
    K. Niedderer;J. MacKrill;S. Clune;Dan Lockton;Geke D. S. Ludden;Andrew Morris;R. Cain;E. Gardiner;Robin Gutteridge;M. Evans;P. Hekkert
  • 通讯作者:
    P. Hekkert
Advancing Hospital Acquired Pressure Injury Prevention with a Data-Driven Transdisciplinary Model
通过数据驱动的跨学科模型推进医院获得性压力性损伤的预防
  • DOI:
    10.1016/j.apmr.2025.03.025
  • 发表时间:
    2025-05-01
  • 期刊:
  • 影响因子:
    3.700
  • 作者:
    Bridget Fowler King;Colleen Johnson;Matthew Grissom;Andrew Morris;Miriam Rafferty
  • 通讯作者:
    Miriam Rafferty
Evaluation of alternative intersection treatments at rural crossroads using simulation software
  • DOI:
    10.1080/15389588.2018.1528357
  • 发表时间:
    2018-01-01
  • 期刊:
  • 影响因子:
  • 作者:
    Sujanie Peiris;Bruce Corben;Michael Nieuwesteeg;Hampton C. Gabler;Andrew Morris;Diana Bowman;Michael G. Lenné;Michael Fitzharris
  • 通讯作者:
    Michael Fitzharris
How electric bikes reduce car use: A dual-mode ownership perspective
电动自行车如何减少汽车使用:一种双模式拥有视角
Objective patient-related outcomes of rapid-response systems — a pilot study to demonstrate feasibility in two hospitals
  • DOI:
    10.1016/s1441-2772(23)02185-3
  • 发表时间:
    2013-03-01
  • 期刊:
  • 影响因子:
  • 作者:
    Andrew Morris;Helen M. Owen;Karen Jones;Jillian Hartin;John Welch;Christian P. Subbe
  • 通讯作者:
    Christian P. Subbe

Andrew Morris的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Andrew Morris', 18)}}的其他基金

Harnessing the power of diverse populations to empower clinical translation of genome-wide association studies of common human disease
利用不同人群的力量,促进人类常见疾病全基因组关联研究的临床转化
  • 批准号:
    MR/W029626/1
  • 财政年份:
    2023
  • 资助金额:
    $ 1936.78万
  • 项目类别:
    Research Grant
Novel statistical methods for transcriptomic imputation to enhance understanding of causal mechanisms underlying human diseases
转录组插补的新统计方法可增强对人类疾病因果机制的理解
  • 批准号:
    MR/V020749/1
  • 财政年份:
    2022
  • 资助金额:
    $ 1936.78万
  • 项目类别:
    Research Grant
UKRI trusted and connected Data and Analytics Research Environments, Phase 1
UKRI 可信且互联的数据和分析研究环境,第一阶段
  • 批准号:
    MC_PC_21005
  • 财政年份:
    2021
  • 资助金额:
    $ 1936.78万
  • 项目类别:
    Intramural
Population Research UK Phase 1: Partnership Design & Dialogue
英国人口研究第一阶段:合作伙伴设计
  • 批准号:
    MC_PC_20024
  • 财政年份:
    2021
  • 资助金额:
    $ 1936.78万
  • 项目类别:
    Intramural
COVID-19: Data and Connectivity – National Core Study (D&C-NCS)
COVID-19:数据和连接 – 国家核心研究 (D
  • 批准号:
    MC_PC_20029
  • 财政年份:
    2020
  • 资助金额:
    $ 1936.78万
  • 项目类别:
    Intramural
Baskerville: a national accelerated compute resource
巴斯克维尔:国家加速计算资源
  • 批准号:
    EP/T022221/1
  • 财政年份:
    2020
  • 资助金额:
    $ 1936.78万
  • 项目类别:
    Research Grant
Open KE Fellowship: Translation of a Miniature CT-DO Sensor from the Laboratory to Real World Applications
开放 KE 奖学金:微型 CT-DO 传感器从实验室到现实世界应用的转化
  • 批准号:
    NE/S006451/2
  • 财政年份:
    2019
  • 资助金额:
    $ 1936.78万
  • 项目类别:
    Research Grant
UKRI ISCF DIH Programme Phase 3– Innovation Gateway, Health Data Research Hubs, and UK Health Data Research Alliance
UKRI ISCF DIH 计划第 3 阶段——创新网关、健康数据研究中心和英国健康数据研究联盟
  • 批准号:
    MC_PC_19002
  • 财政年份:
    2019
  • 资助金额:
    $ 1936.78万
  • 项目类别:
    Intramural
Open KE Fellowship: Translation of a Miniature CT-DO Sensor from the Laboratory to Real World Applications
开放 KE 奖学金:微型 CT-DO 传感器从实验室到现实世界应用的转化
  • 批准号:
    NE/S006451/1
  • 财政年份:
    2018
  • 资助金额:
    $ 1936.78万
  • 项目类别:
    Research Grant
Health Data Research UK - CORE Funds
英国健康数据研究 - CORE 基金
  • 批准号:
    HDR-CORE
  • 财政年份:
    2018
  • 资助金额:
    $ 1936.78万
  • 项目类别:
    Intramural

相似国自然基金

CEACAM5调控Galectin-9介导的CD4+T细胞极化在COVID-19肠屏障损伤的作用机制研究
  • 批准号:
    82370569
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
COVID-19疫情对我国儿童生长发育影响的异质性研究
  • 批准号:
    42371429
  • 批准年份:
    2023
  • 资助金额:
    52.00 万元
  • 项目类别:
    面上项目
传染病模型的稳态切换过程研究及其在治疗COVID-19中的应用
  • 批准号:
    LQ23A010016
  • 批准年份:
    2023
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
COVID-19中线粒体囊泡抑制CD8+T细胞记忆分化的机制研究
  • 批准号:
    82300018
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
COVID-19疫情爆发后武汉地区儿童副流感病毒3型的流行趋势和进化规律研究
  • 批准号:
    n/a
  • 批准年份:
    2023
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
基于 GDF15-IL6 信号轴探究扶正解毒方逆转血管内皮衰老治疗COVID-19的作用与机制
  • 批准号:
    82374392
  • 批准年份:
    2023
  • 资助金额:
    48 万元
  • 项目类别:
    面上项目
多维不平稳和长记忆性的复杂整值时间序列的建模及其在Covid-19研究中的应用
  • 批准号:
    12301358
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
COVID-19疫苗同源、异源加强剂次细胞免疫与体液免疫效应的前瞻性队列研究
  • 批准号:
    n/a
  • 批准年份:
    2023
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目
基于人源细胞3D培养和精密肺切片技术探讨慢阻肺患者COVID-19易感机制研究
  • 批准号:
    LY23H190003
  • 批准年份:
    2023
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目

相似海外基金

SBIR Phase II: Facilitating Early Childhood Teacher and Family Engagement During COVID-19
SBIR 第二阶段:在 COVID-19 期间促进幼儿教师和家庭的参与
  • 批准号:
    2151349
  • 财政年份:
    2022
  • 资助金额:
    $ 1936.78万
  • 项目类别:
    Cooperative Agreement
COVID-19 Immunologic Antiviral therapy with Omalizumab (CIAO trial) - An Adaptive Phase II Randomized-Controlled Clinical Trial
使用奥马珠单抗进行 COVID-19 免疫抗病毒治疗(CIAO 试验)——适应性 II 期随机对照临床试验
  • 批准号:
    475843
  • 财政年份:
    2022
  • 资助金额:
    $ 1936.78万
  • 项目类别:
    Studentship Programs
CoVPN 3008 A Phase 3, Multi-Center, Randomized, Efficacy Study of COVID-19 mRNA Vaccine in Regions with SARS-CoV-2 Variants of Concern
CoVPN 3008 COVID-19 mRNA 疫苗在 SARS-CoV-2 变异关注地区的 3 期、多中心、随机、功效研究
  • 批准号:
    10493538
  • 财政年份:
    2022
  • 资助金额:
    $ 1936.78万
  • 项目类别:
Community-Engaged Research on COVID-19 Testing Among Underserved and/or Vulnerable Populations Phase II
社区参与的针对服务不足和/或弱势群体的 COVID-19 检测研究第二阶段
  • 批准号:
    10544758
  • 财政年份:
    2022
  • 资助金额:
    $ 1936.78万
  • 项目类别:
SBIR Phase II: Machine Learning for Rapid Automated Viral Infectivity Assays (COVID-19)
SBIR 第二阶段:用于快速自动化病毒感染性检测的机器学习 (COVID-19)
  • 批准号:
    2136850
  • 财政年份:
    2022
  • 资助金额:
    $ 1936.78万
  • 项目类别:
    Cooperative Agreement
STTR Phase I: Broad Spectrum Antimicrobial Surface Coating (COVID-19)
STTR 第一阶段:广谱抗菌表面涂层 (COVID-19)
  • 批准号:
    2112033
  • 财政年份:
    2022
  • 资助金额:
    $ 1936.78万
  • 项目类别:
    Standard Grant
SBIR Phase I: A platform for simulating the combined effect of human behavior and environment on airborne infectious spread (COVID-19)
SBIR 第一阶段:模拟人类行为和环境对空气传播传染病(COVID-19)综合影响的平台
  • 批准号:
    2151672
  • 财政年份:
    2022
  • 资助金额:
    $ 1936.78万
  • 项目类别:
    Standard Grant
Community-Engaged Research on COVID-19 Testing Among Underserved and/or Vulnerable Populations Phase II
社区参与的针对服务不足和/或弱势群体的 COVID-19 检测研究第二阶段
  • 批准号:
    10447463
  • 财政年份:
    2022
  • 资助金额:
    $ 1936.78万
  • 项目类别:
COVID-19 Immunologic Antiviral therapy with Omalizumab (CIAO trial) - An Adaptive Phase II Randomized-Controlled Clinical Trial
使用奥马珠单抗进行 COVID-19 免疫抗病毒治疗(CIAO 试验)——适应性 II 期随机对照临床试验
  • 批准号:
    474485
  • 财政年份:
    2022
  • 资助金额:
    $ 1936.78万
  • 项目类别:
    Studentship Programs
CoVPN 3003 A Phase 3 Study to Assess the Efficacy and Safety of Ad26.COV2.S for the Prevention of SARS-CoV-2-mediated COVID-19 in Adults Aged 18 Years and Older LC 3
CoVPN 3003 评估 Ad26.COV2.S 在 18 岁及以上成年人中预防 SARS-CoV-2 介导的 COVID-19 的功效和安全性的 3 期研究 LC 3
  • 批准号:
    10570748
  • 财政年份:
    2022
  • 资助金额:
    $ 1936.78万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了